The notion that companies can offset the impact of the 2.3% device excise tax scheduled to take effect in January by enacting pricing increases is unlikely to play out in reality, in most cases, industry watchers say.
Given anemic market growth trends, “most medical device companies will be unable to pass the device tax on to their...